Yongwei Hu

Yongwei Hu

Auto-generated profile, based on publicly available information

Yongwei Hu

Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
SLSiqi Li
Siqi Li
KLKun Li
Kun Li
KWKang Wang
Kang Wang
HYHaoyuan Yu
Haoyuan Yu
XWXiangyang Wang
Xiangyang Wang
YYYang Yang
Yang Yang
Atezolizumab (anti-PD-L1) combined with bevacizumab (anti-VEGFA) is the first-line immunotherapy for advanced hepatocellular carcinoma (HCC), but the number of patients who benefit from this regimen remains limited. Here, we combine dual PD-L1 and VEGFA blockade (DPVB) with low-dose radiotherapy (LDRT), which rapidly inflames tumors, rendering them vulnerable to immunotherapy. The combinatorial therapy exhibits superior antitumor efficacy mediated by CD8+ T cells in various preclinical HCC models. Treatment efficacy relies upon mobilizing exhausted-like CD8+ T cells (CD8+ Tex) with effector function and cytolytic capacity. Mechanistically, LDRT sensitizes tumors to DPVB by recruiting stem-like CD8+ Tpex, the progenitor exhausted CD8+ T cells, from draining lymph nodes (dLNs) into the tumor via the CXCL10/CXCR3 axis. Together, these results further support the rationale for combining LDRT with atezolizumab and bevacizumab, and its clinical translation.

5 December 2022 in Biomaterials
Verified
Journal Article
Closed access
YHYongwei Hu
Yongwei Hu
YXYanteng Xu
Yanteng Xu
RMRachel L. Mintz
Rachel L. Mintz
XLXing Luo
Xing Luo
YFYouqiang Fang
Youqiang Fang
Mingqiang LiMingqiang Li
Mingqiang Li

9 December 2025 in Biomaterials
Verified
Journal Article
Closed access
YHYongwei Hu
Yongwei Hu
KHKaiming He
Kaiming He
MZMingshen Zhang
Mingshen Zhang
LWLi Wang
Li Wang
LLLei Lyu
Lei Lyu
YYYang Yang
Yang Yang

31 July 2026 in Journal of Hepatology
Verified
Journal Article
Closed access
CZChenghao Zhao
Chenghao Zhao
HYHuzheng Yan
Huzheng Yan
ZLZhixing Liang
Zhixing Liang
HYHaoyuan Yu
Haoyuan Yu
LMLuwen Mu
Luwen Mu
MHMingsheng Huang
Mingsheng Huang